Rankings
▼
Calendar
TEVA Q1 2022 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena
TEVA
Teva Pharmaceutical Industries Limited
$37B
Q1 2022 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$3.7B
-8.1% YoY
Gross Profit
$1.7B
47.5% margin
Operating Income
-$713M
-19.5% margin
Net Income
-$955M
-26.1% margin
EPS (Diluted)
$-0.86
QoQ Revenue Growth
-10.7%
Cash Flow
Operating Cash Flow
-$49M
Free Cash Flow
-$206M
Stock-Based Comp.
$24M
Balance Sheet
Total Assets
$47.1B
Total Liabilities
$36.8B
Stockholders' Equity
$9.3B
Cash & Equivalents
$2.2B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3.7B
$4.0B
-8.1%
Gross Profit
$1.7B
$1.9B
-7.3%
Operating Income
-$713M
$434M
-264.3%
Net Income
-$955M
$77M
-1340.3%
Revenue Segments
Product
$3.1B
86%
Distribution Service
$358M
10%
Product and Service, Other
$129M
4%
License
$38M
1%
Geographic Segments
North America Segment
$1.7B
51%
Europe Segment
$1.2B
34%
International Markets
$492M
15%
← FY 2022
All Quarters
Q2 2022 →